Structures by: Chyall L. J.
Total: 8
Carbamazepine--2,2,2-trifluoroethanol (1/1)
C15H12N2O,C2H3F3O
Acta Crystallographica, Section E (2005) 61, 5 o1312-o1310
a=10.236(2)Å b=12.937(2)Å c=13.614(2)Å
α=62.419(2)° β=88.218(2)° γ=84.286(2)°
Fluoxetine hydrochloride:fumaric acid cocrystal (2:1)
2(C17H19F3NO1Cl1),C4H4O4
Journal of the American Chemical Society (2004) 126, 13335-13342
a=26.6914(8)Å b=7.1807(3)Å c=20.6546(7)Å
α=90.00° β=90.00° γ=90.00°
Fluoxetine hydrochloride:benzoic acid cocrystal (1:1)
(C17H19F3NO1,Cl1),C7H6O2
Journal of the American Chemical Society (2004) 126, 13335-13342
a=14.806(5)Å b=13.179(4)Å c=24.417(7)Å
α=90.00° β=97.738(13)° γ=90.00°
Fluoxetine hydrochloride:succinic acid cocrystal (2:1)
2(C17H19F3NO1Cl1),C4H6O4
Journal of the American Chemical Society (2004) 126, 13335-13342
a=26.620(2)Å b=7.2147(7)Å c=20.8315(19)Å
α=90.00° β=90.00° γ=90.00°
Metformin HCl form I
C4H12ClN5
Crystal Growth & Design (2004) 4, 3 441
a=7.9231(12)Å b=13.894(2)Å c=7.9231(12)Å
α=90.00° β=114.48° γ=90.00°
Metformin HCl form II
C4H12ClN5
Crystal Growth & Design (2004) 4, 3 441
a=7.6261(7)Å b=6.1684(6)Å c=18.1508(16)Å
α=90.00° β=99.447(2)° γ=90.00°
Nabumatone Form I
C15H16O2
Crystal Growth & Design (2002) 2, 6 505
a=21.8603(5)Å b=5.33350(10)Å c=22.2337(6)Å
α=90.00° β=111.9288(11)° γ=90.00°
Nabumatone Form II
C15H16O2
Crystal Growth & Design (2002) 2, 6 505
a=26.9485(4)Å b=5.8773(4)Å c=7.8960(18)Å
α=90.00° β=91.767(3)° γ=90.00°